Inventor · disambiguated record
Wen-Lian Wu
Also filed as: WU WEN-LIAN
37 granted patents·5 pending applications·129 citations·filing 2002–2021
96Inventor score
Files withSCHERING CORP16MERCK SHARP & DOHME11WU WEN-LIAN6ANGEX PHARMACEUTICAL INC5ASBEROM THEODROS2
Top patents by PatentIndex Score
42 records- 0191US9226927B2Gamma secretase inhibitorsWU WEN-LIAN·Filed 2012·Granted Jan 5, 2016·8 cites·12 claims
- 0291US7482360B2Fused tetracyclic mGluR1 antagonists as therapeutic agentsSCHERING CORP·Filed 2006·Granted Jan 27, 2009·15 cites·23 claims
- 0391US6664273B2Piperidine based MCH antagonists for treatment of obesity and CNS disordersSCHERING CORP·Filed 2002·Granted Dec 16, 2003·45 cites·29 claims
- 0483US10689401B2C5-C6-oxacyclic fused iminothiazine dioxide compounds bearing an ether linker as BACE inhibitors, compositions, and their useMERCK SHARP & DOHME·Filed 2017·Granted Jun 23, 2020·2 cites·7 claims
- 0583US9365589B2C5, C6 oxacyclic-fused thiazine dioxide compounds as BACE inhibitors, compositions, and their useMERCK SHARP & DOHME·Filed 2013·Granted Jun 14, 2016·7 cites·14 claims
- 0683US8664411B2Tetrahydropyranochromene gamma secretase inhibitorsWU WEN-LIAN·Filed 2008·Granted Mar 4, 2014·8 cites·23 claims
- 0780US8067621B2Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitorsASBEROM THEODROS·Filed 2007·Granted Nov 29, 2011·5 cites·48 claims
- 0878US7109207B2Spirosubstituted piperidines as selective melanin concentrating hormone receptor antagonists for the treatment of obesitySCHERING CORP·Filed 2003·Granted Sep 19, 2006·13 cites·22 claims
- 0976US7598259B2mGluR1 antagonists as therapeutic agentsSCHERING CORP·Filed 2005·Granted Oct 6, 2009·2 cites·10 claims
- 1075US9499502B25-substituted iminothiazines and their mono- and dioxides as BACE inhibitors, compositions, and their useWU WEN-LIAN·Filed 2012·Granted Nov 22, 2016·3 cites·18 claims
- 1175US8933116B2Gamma secretase inhibitorsWU WEN-LIAN·Filed 2012·Granted Jan 13, 2015·1 cites·15 claims
- 1273US10414774B2Compound useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolc diseaseMERCK SHARP & DOHME·Filed 2017·Granted Sep 17, 2019·1 cites·18 claims
- 1373US9453034B2C2-azaspiro iminothiazine dioxides as BACE inhibitors, compositions, and their useMERCK SHARP & DOHME·Filed 2014·Granted Sep 27, 2016·2 cites·12 claims
- 1471US8618123B2Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitorsSASIKUMAR THAVALAKULAMGARA K·Filed 2008·Granted Dec 31, 2013·3 cites·18 claims
- 1571US8569521B2Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitorsASBEROM THEODROS·Filed 2011·Granted Oct 29, 2013·2 cites·64 claims
- 1671US7485648B2mGluR1 antagonists as therapeutic agentsSCHERING CORP·Filed 2005·Granted Feb 3, 2009·1 cites·20 claims
- 1771US7214691B22-substituted benzimidazole derivatives as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disordersSCHERING CORP·Filed 2004·Granted May 8, 2007·6 cites·25 claims
- 1867US9732088B2C2-carbocyclic iminothiazine dioxides as BACE inhibitors, compositions, and their useMERCK SHARP & DOHME·Filed 2015·Granted Aug 15, 2017·1 cites·9 claims
- 1964US9181236B22-spiro-substituted iminothiazines and their mono-and dioxides as bace inhibitors, compositions and their useWU WEN-LIAN·Filed 2012·Granted Nov 10, 2015·1 cites·15 claims
- 2064US8691832B2Tricyclic heterocycles useful as dipeptidyl peptidase-IV inhibitorsBURNETT DUANE A·Filed 2011·Granted Apr 8, 2014·2 cites·17 claims
- 2164US7989464B2mGluR1 antagonists as therapeutic agentsSCHERING CORP·Filed 2009·Granted Aug 2, 2011·0 cites·11 claims
- 2262US7211574B2Selective D1/D5 receptor antagonists for the treatment of obesity and CNS disordersSCHERING CORP·Filed 2003·Granted May 1, 2007·1 cites·16 claims
- 2361US11008338B2C5-C6-oxacyclic fused iminothiazine dioxide compounds bearing an ether linker as BACE inhibitors, compositions, and their useMERCK SHARP & DOHME·Filed 2020·Granted May 18, 2021·0 cites·10 claims
- 2460US2009137575A1Fused Tetracyclic mGluR1 Antagonists as Therapeutic AgentsSCHERING CORP·Filed 2008·Application pending·0 cites
- 2557US2009082336A1mGluR1 Antagonists as Therapeutic AgentsSCHERING CORP·Filed 2008·Application pending·0 cites
- 2652US2022089612A1Heterocyclic compounds as prmt5 inhibitorsANGEX PHARMACEUTICAL INC·Filed 2021·Application pending·0 cites
- 2751US11685761B2Cyclic di-nucleotide compounds as sting agonistsMERCK SHARP & DOHME·Filed 2018·Granted Jun 27, 2023·0 cites·20 claims
- 2849US9725468B2C5-spiro iminothiazine dioxides as BACE inhibitors, compositions, and their useMERCK SHARP & DOHME·Filed 2014·Granted Aug 8, 2017·0 cites·11 claims
- 2949US6903123B2Azetidinyl diamines useful as ligands of the nociceptin receptor ORL-1SCHERING CORP·Filed 2004·Granted Jun 7, 2005·0 cites·14 claims
- 3048US9051329B2Tricyclic heterocycles useful as dipeptidyl peptidase-IV inhibitorsWU WEN-LIAN·Filed 2012·Granted Jun 9, 2015·0 cites·18 claims
- 3147US11180497B2Cyclic compounds as immunomodulating agentsANGEX PHARMACEUTICAL INC·Filed 2018·Granted Nov 23, 2021·0 cites·25 claims
- 3246US7767815B2Fused tricyclic mGluR1 antagonists as therapeutic agentsSCHERING CORP·Filed 2006·Granted Aug 3, 2010·0 cites·22 claims
- 3346US7511146B22-substituted benzimidazole piperidines analogs as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disordersSCHERING CORP·Filed 2004·Granted Mar 31, 2009·0 cites·13 claims
- 3445US7498441B2Biaryltetrahydroisoquinoline piperidines as selective MCH receptor antagonists for the treatment of obesity and related disordersSCHERING CORP·Filed 2004·Granted Mar 3, 2009·0 cites·19 claims
- 3545US7423149B2Substituted n-aryl amidines as selective D1 dopamine receptor antagonists for the treatment of obesity and CNS disordersSCHERING CORP·Filed 2004·Granted Sep 9, 2008·0 cites·7 claims
- 3645US2003195185A1Azetidinyl diamines useful as ligands of the nociceptin receptor ORL-1SCHERING CORP·Filed 2002·Application pending·0 cites
- 3743US11466047B2Cyclic di-nucleotide compounds as sting agonistsMERCK SHARP & DOHME·Filed 2018·Granted Oct 11, 2022·0 cites·17 claims
- 3843US11098046B2Macrocyclic compounds as TRK kinase inhibitors and uses thereofANGEX PHARMACEUTICAL INC·Filed 2018·Granted Aug 24, 2021·0 cites·21 claims
- 3940US11358949B2Carbamate and urea compounds as multikinase inhibitorsANGEX PHARMACEUTICAL INC·Filed 2018·Granted Jun 14, 2022·0 cites·20 claims
- 4038US10414775B2Compounds useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolic diseaseMERCK SHARP & DOHME·Filed 2017·Granted Sep 17, 2019·0 cites·18 claims
- 4138US2020369667A1Heterocyclic compounds as prmt5 inhibitorsANGEX PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 4237US10071998B2Iminothiadiazine dioxides bearing an amine-linked substituent as BACE inhibitors, compositions, and their useMERCK SHARP & DOHME·Filed 2016·Granted Sep 11, 2018·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Wen-Lian Wu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →